Alzheimer's Therapy Drug: Should We Pay $56,000 to Slow the Loss of Mom's Mind?
3 years ago
1.04K
Aduhelm sparks controversy as a therapy drug for Alzheimer's patients that attacks amyloid plaques in the brain, and slows the decline of memory and problem-solving by about 25% over time. It's not a cure, and it can't even restore lost mental capabilities. Now that the FDA has fast-tracked approval, should American taxpayers cover the $56,000/year per patient cost for relative minor results?
Scott Ott, Stephen Green and Bill Whittle create 240 new episodes of Right Angle annually, thanks to our Members. Join us now at https://BillWhittle.com
Loading 19 comments...
-
15:26
Bill Whittle: Conservative Opinion | Humor
22 days ago $4.15 earnedHarris / Walz Commienomics
2.88K12 -
1:21:51
TheDAMpodcast
3 years ago $0.06 earnedWhen and why should anyone take therapy?
931 -
3:56
NEWSMAX
3 years agoFDA APPROVES NEW ALZHEIMER'S DRUG
1.9K23 -
1:11
IOL-IndependentOnline
3 years ago $0.01 earnedFirst patient receives controversial Biogen Alzheimer's drug
32 -
1:56
KGUN
3 years agoHikers should keep heat safety in mind
2 -
58:17
Josh Pate's College Football Show
4 hours agoWeek 4 Upset Alerts | Florida & Billy Napier Future | Biggest Vegas Movement | Cole Cubelic Joins
33.2K2 -
1:00:00
The StoneZONE with Roger Stone
5 hours agoPennsylvania is the Key to Trump Victory - w/ Cliff Maloney of the PA Chase | The StoneZONE
50.1K8 -
LIVE
Tundra Gaming Live
12 hours agoThe Worlds Worst Horror Streamer Has Heart Attack Playing Phasmophobia
274 watching -
6:33:42
MissesMaam
9 hours agoManager Ma'am 💚✨
64.2K4 -
1:48:05
The Big Mig™
6 hours agoDHS -”5 Assassination Teams Actively Trying To Kill Trump”
86.2K16